Deficiency of Med1 in keratinocytes augments dermal fibrosis and inflammation in scleroderma
- 27 April 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 181, 116667
Abstract
No abstract availableKeywords
Funding Information
- Tianjin Medical University
- National Natural Science Foundation of China (82273563)
- National Natural Science Foundation of China (81972962)
- National Natural Science Foundation of China (82304025)
This publication has 36 references indexed in Scilit:
- Deficiency of inducible nitric oxide synthase alleviates dermal fibrosis and inflammation in sclerodermaInternational Immunopharmacology, 2026
- Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosisAnnals of the Rheumatic Diseases, 2025
- MED1 Deficiency in Macrophages Aggravates Isoproterenol-Induced Cardiac Fibrosis in MiceThe American Journal of Pathology, 2022
- Deficiency of vitamin D receptor in keratinocytes augments dermal fibrosis and inflammation in a mouse model of HOCl-induced sclerodermaBiochemical and Biophysical Research Communications, 2022
- Double knockout of vitamin D receptor and its coactivator mediator complex subunit 1 unexpectedly enhances epidermal permeability barrier function in miceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2021
- The Role of PPAR-γ in Allergic DiseaseCurrent Allergy and Asthma Reports, 2021
- Current Concepts on the Pathogenesis of Systemic SclerosisClinical Reviews in Allergy & Immunology, 2021
- Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2021
- Nrf2 in keratinocytes protects against skin fibrosis via regulating epidermal lesion and inflammatory responseBiochemical Pharmacology, 2020
- The genes of the coactivator TIF2 and the corepressor SMRT are primary 1α,25(OH)2D3 targetsThe Journal of Steroid Biochemistry and Molecular Biology, 2004